(Q36563641)

14 August 2017

1 reference

title

Active surveillance versus radical treatment for favorable-risk localized prostate cancer (English)

1 reference

14 August 2017

1 reference

1

Laurence Klotz

1 reference

14 August 2017

publication date

1 September 2006

1 reference

Current Treatment Options in Oncology

14 August 2017

published in

1 reference

14 August 2017

volume

7

1 reference

14 August 2017

issue

5

1 reference

14 August 2017

page(s)

355-362

1 reference

https://scigraph.springernature.com/pub.10.1007/s11864-006-0003-z

14 August 2017

exact match

0 references

cites work

Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup

1 reference

12 December 2020

Feasibility study: watchful waiting for localized low to intermediate grade prostate carcinoma with selective delayed intervention based on prostate specific antigen, histological and/or clinical progression.

1 reference

12 December 2020

Quality of life after radical prostatectomy or watchful waiting.

1 reference

12 December 2020

Prostate-specific antigen levels in the United States: implications of various definitions for abnormal

1 reference

12 December 2020

Preoperative PSA velocity and the risk of death from prostate cancer after radical prostatectomy

1 reference

12 December 2020

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

1 reference

12 December 2020

Cancer statistics, 2004

1 reference

12 December 2020

Distinguishing clinically important from unimportant prostate cancers before treatment: value of systematic biopsies

1 reference

12 December 2020

Watchful waiting or watchful progression?: Prostate specific antigen doubling times and clinical behavior in patients with early untreated prostate carcinoma.

1 reference

12 December 2020

Overdiagnosis Due to Prostate-Specific Antigen Screening: Lessons From U.S. Prostate Cancer Incidence Trends

1 reference

12 December 2020

Natural history of progression after PSA elevation following radical prostatectomy

1 reference

12 December 2020

Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer

1 reference

12 December 2020

Active surveillance for prostate cancer: for whom?

1 reference

12 December 2020

The volume of prostate cancer in the biopsy specimen cannot reliably predict the quantity of cancer in the radical prostatectomy specimen on an individual basis

1 reference

12 December 2020

Radical prostatectomy versus watchful waiting in early prostate cancer

1 reference

12 December 2020

Insignificant Prostate Cancer in Radical Prostatectomy Specimen: Time Trends and Preoperative Prediction

1 reference

12 December 2020

Identification of insignificant prostate cancers: analysis of preoperative parameters

1 reference

12 December 2020

Cancer statistics, 1993

1 reference

12 December 2020

Use of pretreatment prostate-specific antigen doubling time to predict outcome after radical prostatectomy

1 reference

12 December 2020

The influence of finasteride on the development of prostate cancer

1 reference

12 December 2020

Lead time associated with screening for prostate cancer.

1 reference

12 December 2020

The frequency of carcinoma and intraepithelial neoplasia of the prostate in young male patients

1 reference

12 December 2020

PSA doubling time of prostate carcinoma managed with watchful observation alone

1 reference

12 December 2020

Counseling Men With Prostate Cancer: A Nomogram for Predicting the Presence of Small, Moderately Differentiated, Confined Tumors

1 reference

12 December 2020

Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer

1 reference

12 December 2020

20-year outcomes following conservative management of clinically localized prostate cancer

1 reference

12 December 2020

Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings

1 reference

12 December 2020

Watchful waiting as a treatment option for localized prostate cancer in the PSA era.

1 reference

12 December 2020

Relating biopsy and clinical variables to radical prostatectomy findings: Can insignificant and advanced prostate cancer be predicted in a screening population?

1 reference

12 December 2020

Screening for prostate cancer: estimating the magnitude of overdetection

1 reference

12 December 2020

Correlation of pathologic findings with progression after radical retropubic prostatectomy

1 reference

12 December 2020

Active surveillance for good risk prostate cancer: rationale, method, and results

1 reference

12 December 2020

10.1007/S11864-006-0003-Z

Identifiers

DOI

1 reference

14 August 2017

1 reference